Company intelligence / Profile preview

Lundbeckfonden Emerge

Copenhagen, Denmark

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Lundbeckfonden Emerge is an evergreen corporate venture/seed investment unit of the Lundbeck Foundation that invests in and helps create early-stage Danish biotech companies from discovery through early clinical development.[1][3][8]

Industry: Investors

Partnerships

Novo Holdings (Novo Seeds)Sunstone Life Science VenturesPortfolio collaborations with Danish universities and hospitals (via start-ups; not named individually)

Beyond the preview

Go deeper on Lundbeckfonden Emerge.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lundbeckfonden Emerge.

Explore the full profile